{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:27:49Z","timestamp":1782955669295,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-THK5351 PET is used to image ongoing astrogliosis by estimating monoamine oxidase B levels. <jats:sup>18<\/jats:sup>F-THK5351 preferentially accumulates around the substantia nigra (SN) and periaqueductal gray (PG) in the midbrain under healthy conditions and exhibits a \u201ctrimodal pattern.\u201d In progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), the midbrain <jats:sup>18<\/jats:sup>F-THK5351 uptake can be increased by astrogliosis, collapsing the \u201ctrimodal pattern.\u201d We aimed to elucidate cases in which the \u201ctrimodal pattern\u201d collapses in PSP and CBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>Participants in the PSP (n = 11), CBS (n = 17), Alzheimer disease (n = 11), and healthy control (n = 8) groups underwent <jats:sup>18<\/jats:sup>F-THK5351 PET. Volumes of interest (VOIs) were placed on the SN, PG, and their midpoints. The midbrain uptake ratio (MUR) was calculated to assess the trimodal pattern as follows: MUR = (VOI value on the midpoint)\/(VOI value on the SN and PG). Approximately, the trimodal pattern can be identified at MUR &lt;1 but not at MUR &gt;1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared with the healthy control group, MUR significantly increased in the PSP (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01) and CBS (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01) groups, but was unchanged in the Alzheimer disease group (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.10). In the PSP group, all patients, including 2 with mild symptoms and a short disease duration, showed MUR &gt;1. In the CBS group, MUR varied widely.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In PSP, the trimodal pattern can collapse even in the early phase when symptoms are mild. In CBS, the trimodal pattern may or may not collapse depending on the underlying pathology.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004815","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T16:01:32Z","timestamp":1694188892000},"page":"841-846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome"],"prefix":"10.1097","volume":"48","author":[{"given":"Kenji","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Higashihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of (18)F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"102091","DOI":"10.1016\/j.nicl.2019.102091","article-title":"Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy","volume":"24","year":"2019","journal-title":"Neuroimage Clin"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-018-0556-7","article-title":"Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy","volume":"6","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1097\/RLU.0000000000004272","article-title":"Distribution pattern of the monoamine oxidase B ligand, 18F-THK5351, in the healthy brain","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000001868","article-title":"Potential use of 18F-THK5351 PET to identify Wallerian degeneration of the pyramidal tract caused by cerebral infarction","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/RLU.0000000000002751","article-title":"18F-THK5351 PET can identify astrogliosis in multiple sclerosis plaques","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12880-020-00481-4","article-title":"Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using (18)F-THK5351 positron emission tomography","volume":"20","year":"2020","journal-title":"BMC Med Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/RLU.0000000000003197","article-title":"Head-to-head comparison of the two MAO-B radioligands, 18F-THK5351 and 11C-L-Deprenyl, to visualize astrogliosis in patients with neurological disorders","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/RLU.0000000000002564","article-title":"Monoamine oxidase B binding of 18F-THK5351 to visualize glioblastoma and associated gliosis: an autopsy-confirmed case","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1097\/RLU.0000000000004388","article-title":"Brain PET imaging of 11C-methionine, 18F-FDG, and 18F-THK5351 in a case of lymphomatoid granulomatosis","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1097\/RLU.0000000000003755","article-title":"18F-THK5351 PET can identify core lesions in different amyotrophic lateral sclerosis phenotypes","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"761010","DOI":"10.3389\/fnagi.2021.761010","article-title":"(18)F-THK5351 positron emission tomography imaging in neurodegenerative tauopathies","volume":"13","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-510X(97)00166-4","article-title":"Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy\u2014study in autopsy cases","volume":"152","year":"1997","journal-title":"J Neurol Sci"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fnagi.2019.00249","article-title":"PET imaging of astrogliosis and tau facilitates diagnosis of parkinsonian syndromes","volume":"11","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"163","DOI":"10.12779\/dnd.2018.17.4.163","article-title":"(18)F-THK5351 PET imaging in the behavioral variant of frontotemporal dementia","volume":"17","year":"2018","journal-title":"Dement Neurocogn Disord"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3988\/jcn.2019.15.4.527","article-title":"Relationships between [(1)(8)F]-THK5351 retention and language functions in primary progressive aphasia","volume":"15","year":"2019","journal-title":"J Clin Neurol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","year":"2020","journal-title":"Acta Neuropathol"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/neup.12143","article-title":"Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration","volume":"34","year":"2014","journal-title":"Neuropathology"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","year":"2017","journal-title":"Mov Disord"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"e0158460","DOI":"10.1371\/journal.pone.0158460","article-title":"Dynamic PET measures of tau accumulation in cognitively normal older adults and Alzheimer\u2019s disease patients measured using [18F] THK-5351","volume":"11","year":"2016","journal-title":"PloS One"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1971400918769911","article-title":"A guide to identification and selection of axial planes in magnetic resonance imaging of the brain","volume":"31","year":"2018","journal-title":"Neuroradiol J"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","article-title":"Neuropathology and emerging biomarkers in corticobasal syndrome","volume":"93","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.3346\/jkms.2022.37.e183","article-title":"A case of pathologically confirmed corticobasal degeneration initially presenting as progressive supranuclear palsy syndrome","volume":"37","year":"2022","journal-title":"J Korean Med Sci"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ggi.13229","article-title":"Case of progressive supranuclear palsy detected by tau imaging with [18F]THK-5351 before the appearance of characteristic clinical features","volume":"18","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40658-020-00337-4","article-title":"Direct comparison of brain [(18)F]FDG images acquired by SiPM-based and PMT-based PET\/CT: phantom and clinical studies","volume":"7","year":"2020","journal-title":"EJNMMI Phys"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:11Z","timestamp":1750532471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004815","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,2]]}}}